GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Long-Term Debt

Philogen SpA (STU:78Q) Long-Term Debt : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Long-Term Debt?

Philogen SpA's Long-Term Debt for the quarter that ended in Dec. 2024 was €0.00 Mil.

Philogen SpA's quarterly Long-Term Debt increased from Dec. 2023 (€0.00 Mil) to Jun. 2024 (€1.50 Mil) but then declined from Jun. 2024 (€1.50 Mil) to Dec. 2024 (€0.00 Mil).

Philogen SpA Long-Term Debt Historical Data

The historical data trend for Philogen SpA's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Long-Term Debt Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
- - - - -

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.50 -

Philogen SpA  (STU:78Q) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Philogen SpA Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Long-Term Debt
Comparable Companies
MIL:UBM MIL:ARBS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 OCSE:GMAB INSM BMRN HKSE:02269 SHSE:603392
Traded in Other Exchanges
PHIL:Italy 78Q:Germany
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Website
https://www.philogen.com
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines